Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2018, Article ID 3418306, 7 pages
https://doi.org/10.1155/2018/3418306
Research Article

The Association between LRRK2 G2385R and Phenotype of Parkinson’s Disease in Asian Population: A Meta-Analysis of Comparative Studies

1Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China
2Department of Neurology, Shaanxi Provincial People’s Hospital, Third Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an, Shaanxi 710068, China
3Pediatric Department, The Second People’s Hospital of Longgang District, Shenzhen, Guangdong 518112, China
4Xi’an Medical College, Xi’an, Shaanxi 710068, China

Correspondence should be addressed to Hua Lv; moc.621@3112hvl

Received 15 January 2018; Revised 20 March 2018; Accepted 15 April 2018; Published 10 July 2018

Academic Editor: Cristine Alves da Costa

Copyright © 2018 Wei Di et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Tolleson and J. Y. Fang, “Advances in the mechanisms of Parkinson’s disease,” Discovery Medicine, vol. 15, pp. 61–66, 2013. View at Google Scholar
  2. D. G. Healy, M. Falchi, S. S. O’Sullivan et al., “Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study,” Lancet Neurology, vol. 7, no. 7, pp. 583–590, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Farrer, J. T. Stone, C. H. Lin et al., “Lrrk2 G2385R is an ancestral risk factor for Parkinson’s disease in Asia,” Parkinsonism and Related Disorders, vol. 13, no. 2, pp. 89–92, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Cao, T. Zhang, Q. Xiao et al., “The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson’s disease,” Movement Disorders, vol. 22, no. 16, pp. 2439–2443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. X. K. An, R. Peng, T. Li et al., “LRRK2 Gly2385Arg variant is a risk factor of Parkinson’s disease among Han-Chinese from mainland China,” European Journal of Neurology, vol. 15, pp. 301–305, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. Sun, T. Wang, T. F. Jiang et al., “Effect of a leucine-rich repeat kinase 2 variant on motor and non-motor symptoms in Chinese Parkinson’s disease patients,” Aging and Disease, vol. 7, pp. 230–236, 2016. View at Google Scholar
  7. C. Gao, H. Pang, X. G. Luo, Y. Ren, H. Shang, and Z. Y. He, “LRRK2 G2385R variant carriers of female Parkinson’s disease are more susceptible to motor fluctuation,” Journal of Neurology, vol. 260, no. 11, pp. 2884–2889, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. E. K. Tan, S. Fook-Chong, and Z. Yi, “Comparing LRRK2 Gly2385Arg carriers with noncarriers,” Movement Disorders, vol. 22, no. 5, pp. 749-750, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. M. Kim, J. Y. Lee, H. J. Kim et al., “The LRRK2 G2385R variant is a risk factor for sporadic Parkinson’s disease in the Korean population,” Parkinsonism and Related Disorders, vol. 16, no. 2, pp. 85–88, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Cai, Y. Lin, W. Chen et al., “Association between G2385R and R1628P polymorphism of LRRK2 gene and sporadic Parkinson’s disease in a Han-Chinese population in south-eastern China,” Neurological Sciences, vol. 34, pp. 2001–2006, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. D. F. Stroup, J. A. Berlin, S. C. Morton et al., “Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group,” JAMA, vol. 283, no. 15, pp. 2008–2012, 2000. View at Publisher · View at Google Scholar
  12. A. Liberati, D. G. Altman, J. Tetzlaff et al., “The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration,” Journal of Clinical Epidemiology, vol. 62, no. 10, pp. e1–34, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Fan, T. Lin, K. Xu et al., “Laparoendoscopic single-site nephrectomy compared with conventional laparoscopic nephrectomy: a systematic review and meta-analysis of comparative studies,” European Urology, vol. 62, no. 4, pp. 601–612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. G. A. S. B. Wells, D. O’Connell, J. Peterson, V. Welch, and M. T. P. Losos, The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses, July 2015, http://www.ohri.ca/programs/clinical pidemiology/oxford.asp.
  15. J. P. T. Higgins and S. Green, Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Collaboration, John Wiley and Sons, New York, NY, USA, 2008.
  16. M. Cao, Z. Q. Gu, Y. Li et al., “Olfactory dysfunction in Parkinson’s disease patients with the LRRK2 G2385R variant,” Neuroscience Bulletin, vol. 32, no. 6, pp. 572–576, 2016. View at Publisher · View at Google Scholar · View at Scopus
  17. D. K. Chan, P. W. Ng, V. Mok et al., “LRRK2 Gly2385Arg mutation and clinical features in a Chinese population with early-onset Parkinson’s disease compared to late-onset patients,” Journal of Neural Transmission, vol. 115, pp. 1275–1277, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Di Fonzo, Y. H. Wu-Chou, C. S. Lu et al., “A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan,” Neurogenetics, vol. 7, no. 3, pp. 133–138, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Fu, Y. Zheng, H. Hong et al., “LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson’s disease in a Han Chinese population from Southern Mainland China,” Parkinsonism and Related Disorders, vol. 19, no. 3, pp. 397-398, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Funayama, Y. Li, H. Tomiyama et al., “Leucine-rich repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population,” Neuroreport, vol. 18, no. 3, pp. 273–275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Hong, Y. K. Kim, J. S. Park et al., “Lack of association between LRRK2 G2385R and cognitive dysfunction in Korean patients with Parkinson’s disease,” Journal of Clinical Neuroscience, vol. 36, pp. 108–113, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. H. C. Fung, C. M. Chen, J. Hardy, A. B. Singleton, and Y. R. Wu, “A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan,” BMC Neurology, vol. 6, no. 1, p. 47, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Zhou, X. Luo, F. Li et al., “Association of Parkinson’s disease with six single nucleotide polymorphisms located in four PARK genes in the northern Han Chinese population,” Journal of Clinical Neuroscience, vol. 19, no. 7, pp. 1011–1015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Bouhouche, H. Tibar, R. Ben El Haj et al., “LRRK2 G2019S mutation: prevalence and clinical features in Moroccans with Parkinson’s disease,” Parkinson’s Disease, vol. 2017, Article ID 2412486, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. R. N. Alcalay, A. Mirelman, R. Saunders-Pullman et al., “Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations,” Movement Disorders, vol. 28, no. 14, pp. 1966–1971, 2013. View at Google Scholar
  26. D. W. Li, Z. Gu, C. Wang et al., “Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants,” Journal of Neural Transmission, vol. 122, no. 5, pp. 661–667, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Bostantjopoulou, Z. Katsarou, C. Karakasis, E. Peitsidou, D. Milioni, and N. Rossopoulos, “Evaluation of non-motor symptoms in Parkinson’s Disease: an underestimated necessity,” Hippokratia, vol. 17, pp. 214–219, 2013. View at Google Scholar